Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01906008 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 122
- Enrollment target
NCT01906008: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01906008 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 122 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01906008, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 122 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if minocycline can reduce numbness, pain, and/or loss of motor function in patients with colorectal cancer. In this study, minocycline will be compared to a placebo. The study doctor can explain how the study drug is designed to work. A placebo is not a drug. It looks like the study drug, but it is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
Interventions
- DRUG Placebo
- BEHAVIORAL Questionnaires
- DRUG Minocycline
- BEHAVIORAL Sensory Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-02-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01906008
The ClinicalTrials.gov registry entry for NCT01906008 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01906008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01906008 about?
NCT01906008 is a clinical study titled "Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients". The goal of this clinical research study is to learn if minocycline can reduce numbness, pain, and/or loss of motor function in patients with colorectal cancer. In this study, minocycline will be compared to a placebo. The study doctor can explain how the study drug is designed to work. A placebo ...
What is the current status of trial NCT01906008?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 122 participants. The study started on 2013-11. Estimated completion is 2019-02-14.
What interventions are being tested in trial NCT01906008?
The interventions under investigation include: Placebo (DRUG), Questionnaires (BEHAVIORAL), Minocycline (DRUG), Sensory Test (BEHAVIORAL).
Who is sponsoring clinical trial NCT01906008?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.